行情

CRMD

CRMD

CORMEDIX
NASDAQ

实时行情|Nasdaq Last Sale

15.00
-0.78
-4.94%
盘后: 15.93 +0.93 +6.20% 19:59 02/26 EST
开盘
15.90
昨收
15.78
最高
15.96
最低
14.76
成交量
121.55万
成交额
--
52周最高
18.80
52周最低
2.160
市值
4.82亿
市盈率(TTM)
-19.0476
分时
5日
1月
3月
1年
5年
新闻
财报
公告
公司事件
分析
简况
每日生物技术动向:强生申请COVID-19疫苗批准,Zimmer Biomet的分拆,首次公开募股(IPO)泛滥
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 4)
Benzinga · 02/05 12:44
每日生物技术动向:诺华COVID-19药品上市,默克和罗氏的收益,3次IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 3)
Benzinga · 02/04 12:21
每日生物技术动向:安进收益,GSK-CureVac疫苗合作,Mallinckrodt FDA决定
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 2)
Benzinga · 02/03 12:31
每日生物技术动向:顶点,辉瑞收入,Tiziana COVID-19疫苗数据,Mallinckrodt烧伤治疗的决定日
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 1)
Benzinga · 02/02 13:05
每日生物技术动向:顶点,辉瑞收入,Tiziana COVID-19疫苗数据,Mallinckrodt烧伤治疗的决定日
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 1) Abbott Laboratories (NYSE: ABT) Adamas Pharmaceuticals Inc (NASDAQ: ADMS) (announced FDA approval for an expan...
Benzinga · 02/02 13:05
每日生物技术动向:顶点,辉瑞收入,Tiziana COVID-19疫苗数据,Mallinckrodt烧伤治疗的决定日
Benzinga · 02/02 13:05
Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates
Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of innovation among biopharma companies, as they refer to drugs containing an active ingredient that has never been approved ...
Benzinga · 01/31 10:22
8-K:CorMedix Inc.
(EDGAR Online via COMTEX) -- 0001410098 false 0001410098 2021-01-21 2021-01-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 01/21 14:25
更多
财务预测
每股收益每股净资产每股现金流
实际值(美元)
预测值(美元)
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解CRMD最新的财务预测,通过CRMD每股收益,每股净资产,每股现金流等数据分析CORMEDIX近期的经营情况,然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测CRMD价格均价为25.60,最高价位35.00,最低价为10.00。
EPS
机构持股
总机构数: 99
机构持股: 1,041.62万
持股比例: 32.42%
总股本: 3,213.25万
类型机构数股数
增持
29
81.14万
建仓
20
15.71万
减持
11
3.41万
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-1.05%
制药与医学研究
-0.68%
高管信息
Chairman/Independent Director
Myron Kaplan
Chief Executive Officer/Chief Accounting Officer/Director
Khoso Baluch
Chief Financial Officer/Executive Vice President
Matt David
Chief Financial Officer/Executive Vice President
Matthew David
Executive Vice President/General Counsel
Phoebe Mounts
Executive Vice President
John Armstrong
Executive Vice President
Elizabeth Masson
Director
Paulo Costa
Director
Gregory Duncan
Independent Director
Janet Dillione
Independent Director
Alan Dunton
Independent Director
Steven Lefkowitz
  • 分红
  • 拆股
  • 内部人交易
暂无数据
CRMD 简况
CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.

微牛提供CorMedix Inc.(NASDAQ-CRMD)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CRMD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CRMD股票基本功能。